Send to

Choose Destination
Cancer Immunol Immunother. 1999 Jan;47(5):243-8.

Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2.

Author information

University of Louisville, Department of Surgery, J.G. Brown Cancer Center, Kentucky 40202, USA.


In this review we discuss the effects of interleukin-2 (IL-2) therapy on trafficking of leukocytes and platelets to normal organs. The use of animal models has allowed the elucidation of events leading to damage and/or dysfunction of normal tissues after IL-2 administration. These studies have shown that acute toxicity induced by IL-2 is mediated primarily by neutrophils. Chronic toxicity results from the adhesion and transmigration of activated lymphocytes into normal organs. Platelet-derived microvascular thrombosis also contributes to the vascular toxicity of IL-2. A better understanding of these mechanisms may lead to the development of interventions that will significantly improve the therapeutic efficacy of IL-2.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center